Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

Abstract Objectives General: To assess the safety, efficacy and dose response of convalescent plasma (CP) transfusion in severe COVID-19 patients Specific: a. To identify the appropriate effective dose of CP therapy in severe patients b. To identify the efficacy of the therapy with their end point b...

Full description

Bibliographic Details
Main Authors: Fazle Rabbi Chowdhury, Ashraful Hoque, Forhad Uddin Hasan Chowdhury, Md. Ruhul Amin, Abdur Rahim, M. Mujibur Rahman, Rubina Yasmin, Md. Robed Amin, Md. Titu Miah, Md. Abul Kalam, Md. Sayedur Rahman
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Trials
Subjects:
Convalescent plasma
severe COVID-19
Randomised controlled trial
SARS-CoV-2
BSMMU
Online Access:http://link.springer.com/article/10.1186/s13063-020-04734-z

Internet

http://link.springer.com/article/10.1186/s13063-020-04734-z

Similar Items